Advanced or Metastatic NSCLC (DBCOND0114102)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04177290	A PK Similarity Study of Two Sintilimab Products Produced by Different Processes in Advanced or Metastatic NSCLC Patients	No drug interventions	treatment	1	completed
NCT05435248	Hase 1/2 Study of HS-10375 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)	No drug interventions	treatment	1 / 2	recruiting
NCT04612751	Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer	Carboplatin Datopotamab deruxtecan Durvalumab Rilvegostomig Sabestomig Volrustomig	treatment	1	recruiting
NCT05941897	A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy	Ceralasertib Durvalumab	treatment	2	active_not_recruiting
NCT03673332	Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies	No drug interventions	treatment	4	unknown_status
NCT04526691	Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)	Carboplatin Cisplatin Datopotamab deruxtecan Pembrolizumab	treatment	1	active_not_recruiting
NCT04942301	PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy	No drug interventions	other	1	unknown_status